Nemaura’s SugarBeat Non-Invasive CGM Gets CE Approval

Nemaura received CE approval for its noninvasive, affordable and flexible Glucose Monitor.

Image: Freepik

Nemaura, a Loughborough, England-based medical technology company received CE approval for its non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) SugarBEAT® for use by diabetics and pre-diabetics. This approval allows Nemaura to sell SugarBeat throughout the European Union.

Related Senseonics Gets FDA Approval for Long-Term Implantable CGM Eversense

“We are very pleased to report CE Mark approval in Europe for SugarBEAT®, which is the world’s first non-invasive, needle-free, continuous glucose monitor (CGM).  Importantly, as a daily disposable adhesive skin-patch that sits on the surface of the skin, SugarBEAT® is painless, and versatile in terms of wear time. Given these benefits, we look forward to aggressively entering both the multi-billion-dollar diabetic (insulin and non-insulin dependent) and pre-diabetic markets, said Dr. Faz Chowdhury, CEO of Nemaura.

“In addition, we plan to target the wearable health tech market for health-conscious consumers, which is experiencing explosive growth. Due to the non-invasive nature of the sensor patch and connection to a rechargeable transmitter, SugarBEAT® will allow users the freedom to decide when, and for how long to wear the patch. Moreover, we have a unique competitive advantage, which we believe will make SugarBEAT® the lowest priced CGM device in the industry.  SugarBEAT® is protected by a solid IP portfolio with over 30 issued and pending patents across multiple patent families.”

Related Cellnovo Launches New Mobile App that Connects Directly to CGM Data via HealthKit

Key features of SugarBeat

  • Non-invasive, needle-free, disposable adhesive skin-patch connected to a rechargeable transmitter
  • Lowest priced CGM in the industry
  • Enables users to spend more time in range (TIR) by providing an ambulatory glucose profile (AGP) chart

Nemaura plans to submit application for U.S. FDA approval in mid-2019, the company said in a news release.

Product launch in United Kingdom and Germany is planned for next quarter.

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Sam Draper
June 5, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Lockheed Martin to Use Red 6’s AR-Powered Helmet

New partnership that will deliver advanced 21st Century Security capabilities.

Theranica Envisions a World of Non-Pharmacological Medical Therapy Wearables

Theranica is an Israeli biomedical technology company that develops wearable devices to reduce pain.

OQmented Secures Funding

A maker of MEMS-based displays for AR glasses secures 20 million in an investment round.

Huawei Launching Two New Wearables In Austria, Will Open Experience Store In Vienna

Huawei is launching two new wearables in Austria. In addition to a new fitness band, there is an...
Discover more